Low- and high-grade bladder cancer appraisal via serum-based proteomics approach.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2014-09-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cca.2014.05.012PMID 24875752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder

  2014cited by this paper
• Redox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma.

  2012cited by this paper
• Hypoxia and HIF‐1 increase S100A8 and S100A9 expression in prostate cancer

  2012cited by this paper
• S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells

  2011cited by this paper
• Epidemiologic status of bladder cancer in Shiraz, southern Iran.

  2011cited by this paper
• Proteomic study of sera from patients with bladder cancer: usefulness of S100A8 and S100A9 proteins.

  2010cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.

  2009cited by this paper
• Serum proteomic profiling in patients with bladder cancer.

  2009cited by this paper
• The Role of Carbonic Anhydrase 9 in Regulating Extracellular and Intracellular pH in Three-dimensional Tumor Cell Growths*

  2009cited by this paper
• S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis.

  2009cited by this paper
• S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase‐dependent pathway

  2008cited by this paper
• Urinary markers in bladder cancer.

  2008cited by this paper
• RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis

  2008cited by this paper
• The S100 proteins for screening and prognostic grading of bladder cancer.

  2007cited by this paper
• DAMPs, PAMPs and alarmins: all we need to know about danger

  2007cited by this paper
• Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products.

  2006cited by this paper
• Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients.

  2006cited by this paper
• Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis

  2006cited by this paper
• S100A4 regulates E-cadherin expression in oral squamous cell carcinoma.

  2005cited by this paper
• Down-regulation of S100C is associated with bladder cancer progression and poor survival.

  2005cited by this paper
• Proteomic Analysis of Bladder Cancer Cells Reveals Potential Candidates of Biomarkers in Bladder Tumorigenesis.

  2005cited by this paper
• Annexin V and terminal differentiation of growth plate chondrocytes.

  2005cited by this paper
• Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer

  2004cited by this paper
• DT40 cells lacking the Ca2+-binding protein annexin 5 are resistant to Ca2+-dependent apoptosis

  2002cited by this paper
• Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer.

  2002cited by this paper
• Proteomic Strategies to Reveal Tumor Heterogeneity among Urothelial Papillomas *

  2002influential reference
• Liprin β1, a Member of the Family of LAR Transmembrane Tyrosine Phosphatase-interacting Proteins, Is a New Target for the Metastasis-associated Protein S100A4 (Mts1)*

  2002cited by this paper
• Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer.

  2000cited by this paper
• Annexin V-mediated calcium flux across membranes is dependent on the lipid composition: implications for cartilage mineralization.

  1997cited by this paper
• Cancer statistics

  1989cited by this paper

• Expanding frontiers in liquid biopsy-discovery and validation of circulating biomarkers in renal cell carcinoma and bladder cancer.

  2025cites this paper
• S100A8 promotes the proliferation, migration and invasion in bladder cancer cells

  2025cites this paper
• Emerging methods and techniques for cancer biomarker discovery.

  2024cites this paper
• Advances in Liquid Biopsy for Diagnosis of Bladder Cancer

  2024cites this paper
• A highly sensitive SERS substrate of porous membrane-Ag NPs for kidney cancer detection.

  2024cites this paper
• Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review

  2024cites this paper
• Deciphering Urogenital Cancers through Proteomic Biomarkers: A Systematic Review and Meta-Analysis

  2023cites this paper
• Blood-based liquid biopsy: insights into early detection, prediction, and treatment monitoring of bladder cancer

  2023cites this paper
• Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging

  2023cites this paper
• Metabolic changes preceding bladder cancer occurrence among Korean men: a nested case-control study from the KCPS-II cohort

  2023cites this paper
• Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer.

  2023cites this paper
• Liquid biopsy in urothelial carcinoma: Detection techniques and clinical applications.

  2023cites this paper
• Label-free detection of bladder cancer and kidney cancer plasma based on SERS and multivariate statistical algorithm.

  2022cites this paper
• WWOX Loses the Ability to Regulate Oncogenic AP-2γ and Synergizes with Tumor Suppressor AP-2α in High-Grade Bladder Cancer

  2021cites this paper
• Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.

  2020cites this paper
• Proteomic research and diagnosis in bladder cancer: state of the art review

  2020cites this paper
• Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist

  2020cites this paper
• Identification of a 13-mRNA signature for predicting disease progression and prognosis in patients with bladder cancer

  2019influential citation
• Large‐scale profiling of serum metabolites in African American and European American patients with bladder cancer reveals metabolic pathways associated with patient survival

  2019cites this paper
• Recent advances in the metabolomic study of bladder cancer

  2019cites this paper
• Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer.

  2019cites this paper
• Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology

  2019cites this paper
• Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study

  2019cites this paper
• Uromonitor® as a novel sensitive and specific urine-based test for recurrence surveillance of patients with non-muscle invasive bladder cancer

  2018cites this paper
• Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)

  2018cites this paper
• Unmasking molecular profiles of bladder cancer

  2018cites this paper
• Classifying low-grade and high-grade bladder cancer using label-free serum surface-enhanced Raman spectroscopy and support vector machine

  2018cites this paper
• Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery

  2018cites this paper
• Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy

  2018cites this paper
• Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring

  2018cites this paper
• Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidy

  2017cites this paper
• Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation

  2017cites this paper
• Opium and grade of urothelial bladder cancer

  2017cites this paper
• Significance of S100A8, S100A9 and calprotectin levels in bladder cancer

  2017cites this paper
• Non-invasive detection of bladder cancer through the analysis of driver gene 1 mutations and aneuploidy 2 3

  2017cites this paper
• Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions

  2017cites this paper
• Proteomics and peptidomics: moving toward precision medicine in urological malignancies

  2016cites this paper
• Serum-based protein biomarkers of bladder cancer: A pre- and post-operative evaluation.

  2016cites this paper
• Proteomics in India: the clinical aspect

  2016cites this paper
• Emerging Bladder Cancer Biomarkers and Targets of Therapy.

  2016cites this paper
• Proteometabolomics of bladder cancer: Current and future prospects

  2015cites this paper
• Canine urothelial carcinoma: genomically aberrant and comparatively relevant

  2015cites this paper
• Chapter Two - Recent Developments in Time-of-Flight Mass Spectrometry

  2015cites this paper
• Characterization and noninvasive diagnosis of bladder cancer with serum surface enhanced Raman spectroscopy and genetic algorithms

  2015cites this paper
• Human intestinal mucus proteins isolated by transanal irrigation and proctosigmoidoscopy

  2014cites this paper
• Proteinas do muco intestinal humano isolado por irrigação transanal e retossigmoidoscopia

  2014cites this paper